CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.
CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.
复制标题
作者:
Drummond S;Ramachandran S;Torres E;Huang J;Hehre D;Suguihara C;Young KC
Lung inflammation is a key factor in the pathogenesis of bronchopulmonary dysplasia (BPD). Stromal derived factor-1 (SDF-1) and its receptor chemokine receptor 4 (CXCR4) modulate the inflammatory response. Whether antagonism of CXCR4 will alleviate lung inflammation in neonatal hyperoxia-induced lung injury is unknown. To determine whether CXCR4 antagonism would attenuate lung injury in rodents with experimental BPD by decreasing pulmonary inflammation. Newborn rats exposed to normoxia (RA) or hyperoxia (FiO2=0.9) from postnatal day 2 (P2)-P16 were randomized to receive the CXCR4 antagonist, AMD3100 or placebo (PL) from P5 to P15. Lung alveolarization, angiogenesis, and inflammation were evaluated at P16. As compared to RA, hyperoxic-PL pups had a decrease in alveolarization, reduced lung vascular density and increased lung inflammation. In contrast, AMD3100-treated hyperoxic pups had improved alveolarization and increased angiogenesis. This improvement in lung structure was accompanied by a decrease in bronchoalveolar lavage fluid macrophage and neutrophil count and reduced lung myeloperoxidase activity. CXCR4 antagonism decreases lung inflammation and improves alveolar as well as vascular structure in neonatal rats with experimental BPD. These findings suggest a novel therapeutic strategy to alleviate lung injury in preterm infants with BPD.
登录
查看更多内容
影响因子:
20.1
作者:
Young KC;Torres E;Hatzistergos KE;Hehre D;Suguihara C;Hare JM
通讯作者:
Hare JM
影响因子:
2.5
作者:
Philip, Alistair G. S.
通讯作者:
Philip, Alistair G. S.
影响因子:
45.3
作者:
Devine, SM;Flomenberg, N;DiPersio, JF
通讯作者:
DiPersio, JF
DOI:
10.1165/rcmb.2012-0383oc
发表时间:
2013-05-01
影响因子:
6.4
作者:
Hummler, Stefanie C.;Rong, Min;Wu, Shu
通讯作者:
Wu, Shu
影响因子:
2.7
作者:
McGrath, KE;Koniski, AD;Palis, J
通讯作者:
Palis, J